LEADER 01242nam--2200385---450- 001 990002417830203316 005 20091112092827.0 010 $a0-903067-76-5 035 $a000241783 035 $aUSA01000241783 035 $a(ALEPH)000241783USA01 035 $a000241783 100 $a20050506d2002----km-y0itaa50------ba 101 0 $aeng 102 $aGB 105 $ay---z---001yy 200 1 $aInternational environmental law in national courts$fedited by Michael Anderson and Paolo Galizzi 210 $aLondon$cBritish Institute of International Comparative Law$dcopyr. 2002 215 $aVIII, 246 p.$d24 cm 410 0$12001 454 1 $12001 461 1$1001------$12001 606 0 $aAmbiente naturale$xTutela$xLegislazione internazionale 676 $a341.762 702 1$aANDERSON,$bMichael 702 1$aGALIZZI,$bPaolo 801 0$aIT$bsalbc$gISBD 912 $a990002417830203316 951 $aXXIII.1.G. 183 (IG VIII 14-ING 133)$b42098 G.$cXXIII.1.G. 183 (IG VIII 14-ING)$d00135706 959 $aBK 969 $aGIU 979 $aIANNONE$b90$c20050506$lUSA01$h1420 979 $aRSIAV4$b90$c20091112$lUSA01$h0928 996 $aInternational environmental law in national courts$91058007 997 $aUNISA LEADER 04493nam 22006495 450 001 9910253952903321 005 20200706095030.0 010 $a981-10-5870-9 024 7 $a10.1007/978-981-10-5870-7 035 $a(CKB)4100000000882347 035 $a(DE-He213)978-981-10-5870-7 035 $a(MiAaPQ)EBC5107938 035 $a(PPN)220123845 035 $a(EXLCZ)994100000000882347 100 $a20171018d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPerspectives in Translational Research in Life Sciences and Biomedicine $eTranslational Outcomes Research in Life Sciences and Translational Medicine, Volume 2 /$fby Ena Ray Banerjee 205 $a1st ed. 2017. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2017. 215 $a1 online resource (XII, 132 p. 32 illus., 22 illus. in color.) 311 $a981-10-5869-5 320 $aIncludes bibliographical references at the end of each chapters. 327 $aChapter 1: Tissue Engineering and Nuances of Regenerative Medicine -- Chapter 2: Nanoparticles as anti-inflammatory drug and vehicle -- Chapter 3: Novel Combinatorial Probiotics in Therapy and Prophylaxis -- Chapter 4: Bioprospecting and Bioresource -- Chapter 5: Pharmacogenomics and Molecular Diagnostics -- Chapter 6: Nutraceutical- Prophylactic and Therapeutic Role of Functional Food in Health. 330 $aThis book is a collation of translational research outcomes in the area of life research, which was formerly used mainly for academic pursuits. The studies described focus on innovative interdisciplinary approaches to unraveling problems in life sciences and biomedicine using biodiversity exploration and green technology. The techniques and models presented offer a ready reckoner for researchers in academic institutions and industry, and also provide valuable insights into fundamental research. The book discusses topics such as tissue engineering to create lineage-specific cells for tissue-specific regeneration; how combination cultures of commensalistic bacteria can help boost immunity; development of functional food from natural products from plant, animal, and microbial sources in the nutraceuticals domain; as well as synthesis and mechanisms in nanomedicine and nanoscaffolds in biomedicine. The studies and discourses described touch upon topics that explore biodiversity for the development of disease models, toxicity studies, developmental studies, and harvesting of bioactive compounds for alternative income generation and poverty alleviation, and as a result, bring about economic and ecologic sustainability. This multidimensional and multidisciplinary book focuses on tissue-specific targeting by nanodrugs, development of bioengineering formats for cell- based, nutraceutical-based, functional-food-based and antibody-based green therapy designed tackle multifaceted diseases and syndromes. 606 $aRegenerative medicine 606 $aTissue engineering 606 $aMolecular biology 606 $aGene therapy 606 $aAnimal models in research 606 $aClinical biochemistry 606 $aRegenerative Medicine/Tissue Engineering$3https://scigraph.springernature.com/ontologies/product-market-codes/L16080 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aGene Therapy$3https://scigraph.springernature.com/ontologies/product-market-codes/B12020 606 $aAnimal Models$3https://scigraph.springernature.com/ontologies/product-market-codes/L25050 606 $aMedical Biochemistry$3https://scigraph.springernature.com/ontologies/product-market-codes/H35005 615 0$aRegenerative medicine. 615 0$aTissue engineering. 615 0$aMolecular biology. 615 0$aGene therapy. 615 0$aAnimal models in research. 615 0$aClinical biochemistry. 615 14$aRegenerative Medicine/Tissue Engineering. 615 24$aMolecular Medicine. 615 24$aGene Therapy. 615 24$aAnimal Models. 615 24$aMedical Biochemistry. 676 $a612.028 676 $a571.538 700 $aBanerjee$b Ena Ray$4aut$4http://id.loc.gov/vocabulary/relators/aut$0973671 906 $aBOOK 912 $a9910253952903321 996 $aPerspectives in Translational Research in Life Sciences and Biomedicine$92215706 997 $aUNINA